Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention
NCT03164681 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 126
Last updated 2017-05-24
Summary
Contrast Induced Nephropathy is an acute renal insufficiency defined as a 25% or 0.5 mg/dl increase over the baseline of the serum creatinine level 24 h to 72 h after intravascular administration of a contrast agent.
Conditions
- Contrast-induced Nephropathy
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
sherly boshra · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2018-11-30
- Completion
- 2018-12-30
More Related Trials
-
Contrast Induced Nephropathy Among Vascular Patients Undergoing Lower Limb Angioplasty
NCT04879186 ·Status: UNKNOWN
-
Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy
NCT00693329 ·Status: COMPLETED
-
Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN
NCT02718521 ·Status: UNKNOWN ·Phase: NA
-
A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?
NCT02106234 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
NCT05147831 ·Status: RECRUITING ·Phase: NA
-
Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals
NCT06965764 ·Status: RECRUITING
-
Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
NCT03305874 ·Status: COMPLETED
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio
NCT01400295 ·Status: COMPLETED
-
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
NCT02575092 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Contrast Nephropathy and Nitrates
NCT01999517 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
NCT00558142 ·Status: COMPLETED ·Phase: PHASE4
-
Remote Ischemic Preconditioning to Prevent Contrast Nephropathy
NCT02674451 ·Status: TERMINATED ·Phase: NA
-
Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy
NCT02405377 ·Status: COMPLETED ·Phase: NA
-
Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method
NCT02664246 ·Status: COMPLETED
-
Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy
NCT01292317 ·Status: COMPLETED ·Phase: NA
-
Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans
NCT04606056 ·Status: ACTIVE_NOT_RECRUITING
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System
NCT04279457 ·Status: UNKNOWN ·Phase: PHASE4
-
Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?
NCT01741896 ·Status: COMPLETED ·Phase: NA
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
NCT05271448 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy
NCT01469624 ·Status: UNKNOWN ·Phase: NA
-
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796 ·Status: UNKNOWN ·Phase: EARLY_PHASE1